Adelaida Ferrer

950 total citations
14 papers, 669 citations indexed

About

Adelaida Ferrer is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Endocrinology. According to data from OpenAlex, Adelaida Ferrer has authored 14 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Endocrinology. Recurrent topics in Adelaida Ferrer's work include Cystic Fibrosis Research Advances (4 papers), Legionella and Acanthamoeba research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Adelaida Ferrer is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Legionella and Acanthamoeba research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Adelaida Ferrer collaborates with scholars based in Spain, United States and Romania. Adelaida Ferrer's co-authors include Ramón Orriols, José Bruno Montoro Ronsano, Pilar Suñé, Vicenç Falcó, T. Fernández de Sevilla, José Alegre, Joan Gavaldà, Albert Pahissa, Carles Bravo and J Maestre and has published in prestigious journals such as CHEST Journal, The Pediatric Infectious Disease Journal and The Journal of Heart and Lung Transplantation.

In The Last Decade

Adelaida Ferrer

14 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adelaida Ferrer Spain	11	358	295	142	136	74	14	669
B. Isalska United Kingdom	11	217 0.6×	265 0.9×	127 0.9×	18 0.1×	26 0.4×	21	485
Pradhib Venkatesan United Kingdom	10	269 0.8×	60 0.2×	100 0.7×	47 0.3×	77 1.0×	41	607
Elizabeth A. Henderson Canada	10	191 0.5×	87 0.3×	105 0.7×	85 0.6×	99 1.3×	16	442
Junji H. Higuchi United States	7	151 0.4×	163 0.6×	52 0.4×	23 0.2×	151 2.0×	9	328
G. Döering Germany	8	169 0.5×	490 1.7×	49 0.3×	38 0.3×	49 0.7×	14	630
J.R. Michie United Kingdom	7	84 0.2×	127 0.4×	105 0.7×	50 0.4×	28 0.4×	10	361
Paula Yocum United States	15	202 0.6×	160 0.5×	325 2.3×	23 0.2×	41 0.6×	16	725
L. G. Burman Sweden	12	136 0.4×	100 0.3×	70 0.5×	45 0.3×	27 0.4×	15	423
Antônia Teresinha Tresoldi Brazil	13	219 0.6×	45 0.2×	165 1.2×	29 0.2×	56 0.8×	36	487
Hurşit Apa Türkiye	13	98 0.3×	81 0.3×	101 0.7×	25 0.2×	43 0.6×	50	383

Countries citing papers authored by Adelaida Ferrer

Since Specialization

Citations

This map shows the geographic impact of Adelaida Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adelaida Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adelaida Ferrer more than expected).

Fields of papers citing papers by Adelaida Ferrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adelaida Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adelaida Ferrer. The network helps show where Adelaida Ferrer may publish in the future.

Co-authorship network of co-authors of Adelaida Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Adelaida Ferrer. A scholar is included among the top collaborators of Adelaida Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adelaida Ferrer. Adelaida Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Galling, Britta, et al.. (2016). Antidepressant augmentation and co-initiation treatment in acute major depressive disorder: a systematic review, meta-analysis and metaregression analysis. European Neuropsychopharmacology. 26. S459–S459. 1 indexed citations

Orriols, Ramón, et al.. (2015). Eradication Therapy against <b><i>Pseudomonas aeruginosa</i></b> in Non-Cystic Fibrosis Bronchiectasis. Respiration. 90(4). 299–305. 54 indexed citations

Cruz, María Jesús, et al.. (2012). Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis. International Journal of Clinical Pharmacy. 34(4). 644–650. 27 indexed citations

Gärtner, Silvia, et al.. (2011). Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients. 38. 4295. 1 indexed citations

Sordé, Roger, Vicenç Falcó, Eva Domingo, et al.. (2010). Current and Potential Usefulness of Pneumococcal Urinary Antigen Detection in Hospitalized Patients With Community-Acquired Pneumonia to Guide Antimicrobial Therapy. Archives of Internal Medicine. 171(2). 166–72. 84 indexed citations

Suriñach, José María, et al.. (2008). Respiratory pasteurellosis: Infection or colonization?. Scandinavian Journal of Infectious Diseases. 40(6-7). 555–560. 4 indexed citations

Falcó, Vicenç, Israel Molina, Benito Almirante, et al.. (2006). Tratamiento de la neumonía por Legionella pneumophila. ¿Macrolidos o quinolonas?. Enfermedades Infecciosas y Microbiología Clínica. 24(6). 360–364. 13 indexed citations

Ferrer, Adelaida, Víctor Llorenç, Gemma Codina, & Javier de Gracia. (2005). Nocardiosis y bronquiectasias. ¿Una asociación infrecuente?. Enfermedades Infecciosas y Microbiología Clínica. 23(2). 62–66. 25 indexed citations

Suñé, Pilar, et al.. (2004). Inhaled Tobramycin in Non—Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection with Pseudomonas Aeruginosa. Annals of Pharmacotherapy. 39(1). 39–44. 162 indexed citations

10.

Monforte, Vı́ctor, Joan Gavaldà, Carles Bravo, et al.. (2001). Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. The Journal of Heart and Lung Transplantation. 20(12). 1274–1281. 95 indexed citations

11.

Campins, Magda, et al.. (2000). Nosocomial Legionnaireʼs disease in a childrenʼs hospital. The Pediatric Infectious Disease Journal. 19(3). 228–234. 33 indexed citations

12.

Ja, Capdevila, Segundo Buján, Joan Gavaldà, Adelaida Ferrer, & Albert Pahissa. (1997). Rhodococcus equi Pneumonia in Patients Infected with the Human Immunodefficiency Virus. Report of 2 cases and review of the literature. Scandinavian Journal of Infectious Diseases. 29(6). 535–541. 20 indexed citations

13.

Gracia, Javier de, Marc Miravitlles, Cristina Mayordomo, et al.. (1997). Empiric Treatments Impair the Diagnostic Yield of BAL in HIV-Positive Patients. CHEST Journal. 111(5). 1180–1186. 26 indexed citations

14.

Falcó, Vicenç, et al.. (1991). Legionella pneumophila. CHEST Journal. 100(4). 1007–1011. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact